SNSE
Sensei Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.85
−22.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.10x
- Price / sales
- -3.83x
- Price / cash flow
- -0.77x
Enterprise value
- Enterprise value
- $145.3M
- EV / sales
- -29.95x
- EV / EBITDA
- -0.79x
- EV / EBIT
- -0.78x
- Market cap
- $18.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026